Gefitinib

Indication

Chemotherapy for stage IV (metastatic) cancer

• Gefitinib (Iressa) 250 mg po qd

References

Cappuzzo F et al. Prospective study of gefitinib in epidermal growth factor receptor fluorescence in site hybridization-positive/phospho-akt-positive or never smoker patients with advanced non-small-cell lung cancer: The ONCOBELL trial. J Clin Oncol 2007; 25:2248

Niho S et al. Results of a randomized phase III study to compare the overall survival of gefitinib (iressa) versus docetaxel in Japanese patients with non-small-cell lung cancer who failed one or two chemotherapy regimens. 2007 ASCO annual meeting. Abstract LBA 7509